Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating depression in the medically ill.

Dan V Iosifescu1

  • 1Depression Clinical and Research Program, Massachusetts General Hospital, 50 Staniford Street, Suite 401, Boston, MA 02114, USA. diosifescu@partners.org

The Psychiatric Clinics of North America
|March 17, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sodium-Glucose Cotransporter 2 Inhibitors and Dementia Risk in Patients With Psychiatric Disorders.

JAMA network open·2026
Same author

Comparative diagnostic accuracy of panic provocation tests: A meta-analysis.

Journal of psychiatric research·2026
Same author

The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD<sup>✰</sup>.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same author

Decisional reference point pathology: A cognitive mechanism for and a correlate of major depressive disorder in humans.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).

International clinical psychopharmacology·2026
Same author

Meta-analysis and meta-regression of diagnostic test accuracy of connectome-based predictive modeling in OCD.

Brain imaging and behavior·2026

Patients with depression and medical illness often face treatment resistance. More intensive antidepressant strategies and increased suspicion for depression in medically ill individuals are recommended for better outcomes.

Area of Science:

  • Psychiatry
  • Internal Medicine
  • Clinical Psychology

Background:

  • Depression frequently co-occurs with medical illnesses, leading to increased morbidity and reduced functional status.
  • While standard antidepressants can help, patients with comorbid medical conditions show lower recovery and remission rates and higher relapse rates compared to those with Major Depressive Disorder (MDD) alone.
  • Comorbid medical illness is a significant indicator of treatment resistance in MDD.

Purpose of the Study:

  • To review the impact of comorbid medical illness on the treatment of Major Depressive Disorder (MDD).
  • To identify effective treatment strategies for depressed patients with coexisting medical conditions.
  • To highlight the need for adjusted clinical approaches in managing MDD with medical comorbidities.

Main Methods:

Related Experiment Videos

  • Review of clinical studies examining depression in patients with comorbid medical conditions.
  • Analysis of treatment outcomes, including recovery, remission, and relapse rates.
  • Evaluation of the efficacy of collaborative treatment models.

Main Results:

  • Patients with comorbid medical illness experience poorer treatment outcomes for depression, including lower remission and higher relapse rates.
  • Comorbid medical conditions are associated with increased treatment resistance in MDD.
  • Collaborative treatments integrating antidepressants, psychotherapy, education, and case management show promise.

Conclusions:

  • Increased vigilance for depression is crucial in medically ill patients.
  • More intensive antidepressant treatment approaches are warranted for depressed patients with medical comorbidities.
  • Addressing comorbid medical illness is essential for overcoming treatment resistance in MDD.